Atossa Therapeutics (ATOS) Revenue (2011 - 2015)

Atossa Therapeutics (ATOS) has reported Revenue for 5 consecutive years, with $1758.0 the latest figure, recorded in Q4 2015.

• On a quarterly basis, Revenue fell 35.2% year-over-year to $1758.0 in Q4 2015; TTM through Sep 2016 was $1758.0, a 35.2% decrease from a year earlier, with the FY2015 full-year figure at $1758.0, down 95.62% from the prior year.
• Revenue was $1758.0 for Q4 2015 at Atossa Therapeutics, down from $2713.0 in the prior quarter.
• Over five years, Revenue peaked at $326078.0 in Q2 2013 and troughed at $1500.0 in Q4 2011.
• A 5-year average of $82699.7 and a median of $50963.0 in 2012 frame the typical range for Revenue.
• Across the five-year window, Revenue soared 6463.73% in 2012 and sank 96.97% in 2014, its largest moves.
• Over 5 years, Revenue stood at $1500.0 in 2011, then soared by 6463.73% to $98456.0 in 2012, then slumped by 52.05% to $47213.0 in 2013, then slumped by 94.25% to $2713.0 in 2014, then sank by 35.2% to $1758.0 in 2015.
• The last three Revenue figures came in at $1758.0 (Q4 2015), $2713.0 (Q4 2014), and $3426.0 (Q3 2014), per Business Quant data.